Inventor

LIPOVSEK DASA

US56 patents

⚠️ This page may combine multiple inventors who share the name “LIPOVSEK DASA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIPOVSEK DASA

BRISTOL MYERS SQUIBB CO

Fibronectin based scaffold domain proteins that bind to myostatin

Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind to myostatin

PD-L1 binding polypeptides for imaging

Therapeutic uses of modified FGF-21 polypeptides

Fibronectin binding domains with reduced immunogenicity

Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

Fibronectin binding domains with reduced immunogenicity

Fibronectin binding domains with reduced immunogenicity

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin binding domains with reduced immunogenicity

Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides

Serum albumin-binding fibronectin type III domains

Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof

Fibronectin based scaffold domain proteins that bind PCSK9

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Stabilized fibronectin based scaffold molecules

Fibronectin binding domains with reduced immunogenicity

Methods for the selection of binding proteins

Fibronectin binding domains with reduced immunogenicity

Stabilized fibronectin based scaffold molecules

Serum albumin-binding fibronectin type III domains

Fibronectin based scaffold domain proteins that bind to myostatin

Fibronectin based scaffold domain proteins that bind to myostatin

PET imaging with PD-L1 binding polypeptides

PD-L1 binding polypeptides for imaging

Glypican-3-binding fibronectin based scaffold molecules

Fast-off rate serum albumin binding fibronectin type III domains

Fast-off rate serum albumin binding fibronectin type III domains

Glypican-3-binding fibronectin based scaffold molecules

Stabilized fibronectin based scaffold molecules

Methods for the selection of binding proteins

Methods for the selection of binding proteins

Serum albumin-binding fibronectin type III domains

Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof

Fibronectin based scaffold proteins

Fibronectin binding domains with reduced immunogenicity

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind to myostatin

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof

COMPOUND THERAPEUTICS INC

Protein scaffolds for antibody mimics and other binding proteins

Protein scaffolds for antibody mimics and other binding proteins

CAMPHAUSEN RAY

Fibronectin based scaffold domain proteins that bind to PCSK9

LIPOVSEK DASA

Protein scaffolds for antibody mimics and other binding proteins